Mankind Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
MANKIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mankind Pharma has submitted a routine compliance certificate to the exchanges for the quarter ended June 30, 2025. The certificate was issued by KFin Technologies, the company's Registrar and Share Transfer Agent, confirming that no requests for dematerialization or rematerialization of shares were received between April 1, 2025 and June 30, 2025. This is a standard quarterly filing mandated by SEBI under Regulation 74(5). The disclosure is purely procedural and does not involve any corporate action, fundraising, or change in shareholding structure.
No impact on shareholders or stock price. This is a routine regulatory compliance filing with no material information for investors.